Clinical Trial

Physiological Adaptations to Simulated Intermittent Altitude

Study Description

Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance

The investigators expect to find that different intensity and altitude exposure levels will show what kind of intermittent exposure protocol is more beneficial to athletes and healthy individuals that experience acute exposure to altitude during exercise. This may furthermore be related to acute altitude exposure for recreational exercise use as well.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Placebo simulated altitude

Participants will exercise at sea level at similar percentage of intensities to the simulated altitude group.

Simulated altitude

Participants will exercise in simulated altitude will range between 2100 feet and 16400 feet and will increase according to arm guidelines

Additional Information

Official Study Title

Investigation of Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance

Clinical Trial ID

NCT03743610

ParticipAid ID

eZ6Z6e